RETA Analyst Forecast: Expert Predictions and Future Outlook

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date	Details
08/08/2022	Goldman Sachs	Madhu Kumar	$76.00	$24.13	214.96%

Date

Brokerage Firm

Analyst Name

Price Target

Price when Posted

Upside/Downside
on Report Date

Details

08/08/2022

Goldman Sachs

Madhu Kumar

$76.00

$24.13

214.96%

Reata Pharmaceuticals, Inc. Frequently Asked Questions

What analysts cover Reata Pharmaceuticals, Inc.?

Reata Pharmaceuticals, Inc. has been rated by research analysts at Goldman Sachs, Robert W. Baird, Citigroup in the past 90 days.

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.